Gastroenteritis clinical trials
The registry lists 243 studies for Gastroenteritis across more than 10 countries. 15 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-22.
Status
- Completed
- 168
- Status unknown
- 25
- Terminated
- 20
- Recruiting
- 12
- Withdrawn
- 9
- Active, not recruiting
- 5
Phase
- Phase 3
- 54
- Phase 2
- 31
- Phase 4
- 27
- Phase 1
- 26
- Early Phase 1
- 1
Where
- United States
- 55
- Canada
- 23
- France
- 15
- India
- 11
- Italy
- 10
- Poland
- 9
Who runs them
GlaxoSmithKline (23) · Merck Sharp & Dohme LLC (12) · National Institute of Allergy and Infectious Diseases (NIAID) (12) · Medical University of Warsaw (6) · The Hospital for Sick Children (6) · HilleVax (4) · Allakos Inc. (4) · NIZO Food Research (4)
Studies
Recruiting first, then most recently updated. Showing 50 of 243 — search for more.
- A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in GermanyRecruitingNCT071023681 country
- Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute DiarrheaRecruitingNCT07285785Phase 41 country
- Autologous Stem Cell Transplant for Crohn's DiseaseRecruitingNCT03219359Phase 21 country
- Diagnosis of Abdominal Pain Using RNA Levels: The NATURAL StudyRecruitingNCT075793121 country
- Fortified Oral Rehydration Therapy for Pediatric DiarrheaRecruitingNCT06137014Phase 1/21 country
- Follow-up Automatically vs. As-Needed Comparison (FAAN-C) TrialRecruitingNCT05471908Not applicable1 country
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT017931682 countries
- Prevalence of Anemia and Growth Assessment in Acute GastroenteritisRecruitingNCT060383051 country
- Clinical Trial to Investigate the Efficacy and Safety of Ondansetron (Danset - Adwia) Versus Placebo Plus the Standard of Care in the Treatment of Nausea and Vomiting in Adult Patients With Acute GastroenteritisNot yet recruitingNCT05876585Phase 3
- Prevalence of Faecal Bacteriophage in Patients With Digestive SymptomsNot yet recruitingNCT065247911 country
- National, Multicenter, Retrospective, Prospective Study to Evaluate Pediatric Gastrointestinal Eosinophilic DisordersRecruitingNCT052199031 country
- Pediatric and Ambulatory Research in Infectious DiseasesRecruitingNCT044714931 country
- Evaluation of Recombinant Norovirus Hexavalent Vaccine in Healthy SubjectsNot yet recruitingNCT05805618Early Phase 1
- Efficacy of Lactose-free Milk in Treating Acute Gastroenteritis in InfantsRecruitingNCT05634603Not applicable1 country
- A Trial to Assess the Safety, Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and IndiaRecruitingNCT04010448Phase 31 country
- Racecadotril Versus Standard Treatment in Decreasing the Duration of Acute Diarrhoea in ChildrenCompletedNCT06529497Phase 1/21 country
- A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eosinophilic GastroenteritisCompletedNCT05214768Phase 31 country
- Study of the Role of Pomegranate Juice Ellagitannins in the Modulation of Inflammation in Inflammatory Bowel DiseaseCompletedNCT03000101Not applicable1 country
- Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic EsophagitisCompletedNCT04991935Phase 315 countries
- A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese InfantsCompletedNCT06331156Phase 31 country
- Expanded Access Protocol for Patients With Eosinophilic EsophagitisNo longer availableNCT050951161 country
- Burden of Recreational Water Illness Due to Exposure to Cyanobacteria and Their Toxins in Freshwater Beaches in CanadaActive, not recruitingNCT065791701 country
- Serologic Assay Validation and Proficiency Testing of HIL-214 in AdultsCompletedNCT05972733Phase 21 country
- 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)CompletedNCT05634746Phase 32 countries
- A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)Active, not recruitingNCT0184856121 countries
- Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)TerminatedNCT05251909Phase 39 countries
- Efficacy and Safety of Two Doses of HIL-214 in ChildrenTerminatedNCT05281094Phase 2/37 countries
- NNITS-Nitazoxanide for Norovirus in Transplant Patients StudyCompletedNCT03395405Phase 21 country
- A Double-Blind Placebo-Control Dose Escalating Study to Evaluate the Safety and Immunogenicity of dmLT by Oral, Sublingual and Intradermal Vaccination in Adults Residing in an Endemic AreaTerminatedNCT03548064Phase 12 countries
- Sucrose at Triage for Acute Gastroenteritis Episode in ChildrenCompletedNCT05378776Not applicable1 country
- Challenge Non-Typhoidal Salmonella (CHANTS) StudyActive, not recruitingNCT05870150Not applicable1 country
- Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritisCompletedNCT03851835Phase 31 country
- ROTA-biotic: Measuring the Impact of Rotavirus Vaccines on Paediatric Antibiotic UsageCompletedNCT068820702 countries
- Safety and Immunogenicity of HIL-214 in Healthy Japanese InfantsCompletedNCT06007781Phase 11 country
- Safety and Immunogenicity of HIL-214 With Routine Pediatric VaccinesCompletedNCT05836012Phase 2/33 countries
- Phase I Norovirus Challenge ModelCompletedNCT04174560Phase 11 country
- Inferior Vena Cava Collapsibility and Distensibility Assessment in Critical Care.CompletedNCT06516692Not applicable1 country
- Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and ToddlersActive, not recruitingNCT05621655Phase 21 country
- Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 WeeksCompletedNCT06025695Phase 31 country
- Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)CompletedNCT04563533Phase 1/21 country
- Validation of a Boindicator as Monitoring Tool for Oyster Norovirus OutbreakWithdrawnNCT06568380Not applicable1 country
- Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074)CompletedNCT04481191Phase 31 country
- Utility of Ultrasound Assessment of the Inferior Vena Cava in Patients With Sepsis and DehydrationTerminatedNCT02568189Not applicable1 country
- Clinical Effectiveness and Safety of a Novel Oral Rehydration SolutionCompletedNCT05247879Not applicable1 country
- Gastroenteritis in Pediatric Population of QatarStatus unknownNCT030463421 country
- Optimising Rotavirus Vaccine in Aboriginal ChildrenActive, not recruitingNCT02941107Phase 41 country
- An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic DuodenitisCompletedNCT03664960Phase 21 country
- Oral Nitazoxanide in Acute Gastroenteritis in Australian Indigenous ChildrenTerminatedNCT02165813Phase 2/31 country
- A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic GastroenteritisCompletedNCT03496571Phase 21 country
- Admission Pattern Among Children With Gastro-intestinal Infections Before and During the Covid-19 PandemicCompletedNCT062116211 country